SCHEMBL6788274

SCHEMBL6788274

CC(C(=O)O)c1ccc(N2C(=O)C=CC2=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 10/20 0.65
DDAH1 O94760 1/20 0.55
FAAH O00519 4/20 0.54
PTGS2 P35354 5/20 0.50
PKM P14618 2/20 0.50
HSP90AA1 P07900 2/20 0.50
MAPK1 P28482 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 3/20 0.48
TP53 P04637 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NFKB1 P19838 2/20 0.48
MEN1 O00255 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
KMT2A Q03164 1/20 0.48
NPC1 O15118 1/20 0.48
PGR P06401 1/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24452742 0.84 MGLL (0.62) MGLLDDAH1FAAHPKMHSP90AA1
SCHEMBL6790912 0.81 CA12 (0.56) PTGS2PKMLMNATP53SMN1; SMN2
SCHEMBL3482327 0.79 MGLL (1.00) MGLLDDAH1FAAHPKMHSP90AA1
SCHEMBL2363989 0.79 MGLL (0.77) MGLLDDAH1FAAHPKMHSP90AA1
SCHEMBL6789729 0.78 KMT2A (0.62) PTGS2PKMNPSR1LMNATP53
SCHEMBL3414901 0.78 MGLL (0.54) MGLLDDAH1FAAHPKMHSP90AA1
SCHEMBL59197 0.78 PTGS2 (0.74) PTGS2LMNANFKB1PTGS1CYP2C9
SCHEMBL29417800 0.76 MGLL (0.67) MGLLDDAH1FAAHPKMHSP90AA1
SCHEMBL19156143 0.76 MGLL (0.71) MGLLDDAH1FAAHPKMHSP90AA1
SCHEMBL23599861 0.76 MGLL (0.71) MGLLDDAH1FAAHPKMHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040019046-A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents PHARMACIA ITALIA SPA (IT) 2004-01-29 US disclosed
EP-1345909-A1 PHENYLACETAMIDO-PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2003-09-24 EP disclosed
WO-2002048114-A1 PHENYLACETAMIDO- PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA S.P.A. (IT) 2002-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019046-A1 Phenylacetamido-pyrazole derivatives and their use as antitumor agents DCK, CCNK, CDK2 MGLL 4455/4885DDAH1 1512/4885FAAH 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.